Search

everythinglearnresearchcommunity

for

Search:↓

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Tofacitinib may effectively treat folliculitis decalvans.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Abatacept may help some people with alopecia areata regrow hair.

Tph cells are linked to the severity of systemic lupus erythematosus.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.